Carolyn Cross reduces stake in Ondine Biomedical to 23%
NeutralFinancial Markets

Carolyn Cross has reduced her stake in Ondine Biomedical to 23%. This change in ownership may impact the company's future direction and investor confidence.
— via World Pulse Now AI Editorial System